Irbesartan
- Product NDC
- 70771-1161
- 11-digit product format
- 707711161
- Labeler code
- 70771
- Product ID
- 70771-1161_120947cf-df25-4bbc-93bc-1ea48be2bdb4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Irbesartan
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA079213
- Marketing category
- ANDA
- Marketing start
- 2017-12-08
- Marketing end
- 0000-00-00
- Substance
- IRBESARTAN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1161-0 | 70771116100 | 1000 TABLET in 1 BOTTLE (70771-1161-0) | 1000 tablet | 2017-12-08 | 0000-00-00 | No | No | Current |
| 70771-1161-3 | 70771116103 | 30 TABLET in 1 BOTTLE (70771-1161-3) | 30 tablet | 2017-12-08 | 0000-00-00 | No | No | Current |
| 70771-1161-4 | 70771116104 | 10 BLISTER PACK in 1 CARTON (70771-1161-4) > 10 TABLET in 1 BLISTER PACK (70771-1161-2) | 10 blister pack | 2017-12-08 | 0000-00-00 | No | No | Current |
| 70771-1161-5 | 70771116105 | 500 TABLET in 1 BOTTLE (70771-1161-5) | 500 tablet | 2017-12-08 | 0000-00-00 | No | No | Current |
| 70771-1161-9 | 70771116109 | 90 TABLET in 1 BOTTLE (70771-1161-9) | 90 tablet | 2017-12-08 | 0000-00-00 | No | No | Current |